Table 3. Overall complications and severity grade based on Clavien-Dindo classification.
Variable | Author | Ileal conduit | Cutaneous ureterostomy | p | |
---|---|---|---|---|---|
No Complications | Deliveliotis et al. (19) | n (%) | 0 (0%) | 8 (27.6%) | - |
Longo et al. (21) | n (%) | 0 (0%) | 9 (25.7%) | - | |
Knap et al. (20) | ND | - | - | - | |
Meng et al. (26) | n (%) | 52 (53.1%) | 106 (75.2%) | p=0.01 | |
Wuethrich et al. (22) | n (%) | 56 (31.5%) | 5 (45.5%) | ||
Kilciller et al. (23) | n (%) | 55 (83.48%)-early | 26 (66.48%) early | ||
53 (79.11%) late | 28 (82.3%) late | ||||
Suzuki et al. (24) | ND | - | - | ||
Arman et al. (25) | ND | - | - | - | |
Clavien 1-2 | Deliveliotis et al. (19) | n (%) | 28 (100%) | 16 (55.2%) | - |
Longo et al. (21) | n (%) | 48 (100%) | 20 (57.1%) | - | |
Knap et al. (20) | ND | - | - | - | |
Meng et al. (26) | n (%) | 32 (32.7%) | 25 (17.7%) | - | |
Wuethrich et al. (22) | n (%) | 66 (37.1%) | 3 (27.3%) | - | |
Kilciller et al. (23) | ND | - | - | - | |
Suzuki et al. (24) | ND | - | - | - | |
Arman et al. (25) | ND | - | - | - | |
Clavien 3-5 | Deliveliotis et al. (19) | n (%) | 10 (40%) | 5 (17.2%) | 0.0025 |
Longo et al. (21) | n (%) | 12 (34.3%) | 6 (17.1%) | 0.0002 | |
Knap et al. (20) | ND | - | - | - | |
Meng et al. (26) | n (%) | 14 (14.3%) | 10 (7.1%) | 0.0018 | |
Wuetrich et al. (22) | n (%) | 56 (21.5%) | 3 (27.3%) 74 (85.1%) | 0.6188 | |
Kilciller et al. (23) | n(%) | 72 (82.4%) | 2 (4.2%) | 0.837 | |
Suzuki et al. (24) | n (%) | 2 (9.1%) | - | 0.711 | |
Arman et al. (25) | - | - | - | - | |
Mortality | Deliveliotis et al. (19) | n (%) | 1 (4%) | 0 (0) | 0.128 |
Longo et al. (21) | n (%) | 1 (2.8%) | 1 (2.8%) | 0.470 | |
Knap et al. (20) | ND | - | - | - | |
Meng et al. (26) | n (%) | 2 (2.0%) | 1 (0.7%) | 0.752 | |
Wuethrich et al. (22) | n (%) | 0 | 0 | - | |
Kilciller et al. (23) | ND | - | - | - | |
Suzuki et al. (24) | ND | - | - | - | |
Arman et al. (25) | - | - | - | - |